Jazz Pharmaceuticals Announces Third Quarter 2015 Financial Results by longitudeadmin | Nov 9, 2015 | Portfolio News
Collegium Announces FDA Tentative Approval for Xtampza™ ER, a Novel Abuse-Deterrent Analgesic for Chronic Pain by longitudeadmin | Nov 9, 2015 | Portfolio News
Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Third Quarter 2015 Financial Results by longitudeadmin | Nov 5, 2015 | Portfolio News
Corcept Therapeutics Announces Third Quarter 2015 Results and Provides Corporate Update by longitudeadmin | Nov 5, 2015 | Portfolio News
Aimmune Therapeutics Announces Financial Results for the Third Quarter 2015 by longitudeadmin | Nov 4, 2015 | Portfolio News
